A longitudinal study of motor subtypes in delirium: Frequency and stability during episodes
Introduction
Although delirium is considered a unitary syndrome with prevalent core symptoms, it is a heterogeneous condition for causation and outcome, especially across the major age ranges. Those with hyperactivity are more readily recognised but this may contribute to poorer outcomes among hypoactive cases. Meagher [1] reviewed the evidence that delirium patients described according to motor/psychomotor subtypes are reported to be associated with differences for prognostic parameters. However much of the literature utilised different subtype criteria and symptom severity thresholds such that subtype incidence and outcomes are inconsistent across studies [2]. Notably, referral samples are usually confounded by significant under-recognition of hypoactive patients which affects the accuracy of study results. Drug treatment response differences for motor subtypes have been addressed in only a few studies [[3], [4], [5], [6]] but differential psychopharmacology has not yet been clearly delineated.
Moreover, interpretation of the existing literature is hindered by a lack of consistency in methodology. Motor subtype checklists include many nonspecific behavioural symptoms, may only require one symptom for a subtype to be present (and that might not be specifically motor in nature), and have not been validated against controls or objective motor measures. Motor activity items from rating scales have also been used in some studies and tend to focus on pure motor disturbances in their definitions. Meagher et al. [7] validated a new motor subtype scale, the Delirium Motor Subtype Scale (DMSS), focused only on motor features and which differentiated delirious from nondelirious subjects. Moreover, subsequent work has indicated that DMSS defined subtypes match objective (electronic) measures of motion [8]. Subtypes identified cross-sectionally using the DMSS had comparable neuropsychological profiles but differed for noncognitive symptoms of delirium [9]. Furthermore, preliminary work has suggested that the DMSS has predictive validity for outcome in delirium [7]. No other delirium subtype method has undergone such rigorous validation.
Most phenomenological research describes cross-sectional assessment of delirium and therefore little is known about the stability of motor symptoms and subtypes over the course of a delirium episode within an individual [1]. To fully capture the character of the syndrome, which includes fluctuations in severity over a 24-hour period, phenomenological issues must be explored with longitudinal studies that assess clinical profile throughout the duration of an episode. The increased interest in longitudinal study of delirium has highlighted that the course of delirium is much less reversible than traditional concepts have emphasised and that a significant number of patients experience persistent symptoms that can progress to long-term cognitive impairment [10] although the relevance of factors such as variations in underlying aetiology, ageing, genetic factors and treatment settings in shaping illness course over time remains uncertain [11].
We describe 100 consecutive cases of DSM-IV diagnosed delirium occurring in a palliative care setting that were assessed for motor profile, cognition and delirium phenomenology longitudinally for up to 9 visits (6 weeks) during the course of their delirium episodes. The specific aim of this report was to explore how motor profile (DMSS subtype) evolves during delirium episodes and relates to delirium syndromal severity using well-validated tools. In particular, we wished to determine [1] the intra-individual stability of motor subtype classification [2] whether the frequency of motor subtypes changes with increased duration of delirium (e.g. whether more persistent illness involves greater prominence of hypoactive profile [3]) the extent to which mixed subtype overlaps over time with hypoactive and hyperactive subtypes. A separate report addresses the relationship between motor subtypes and aetiology, medication exposure and prognosis [12].
Section snippets
Subjects and design
We conducted a prospective, longitudinal study of phenomenological profile in consecutive adult cases of delirium occurring in patients with cancer diagnoses receiving care at Milford Hospice palliative care inpatient service in Limerick, Ireland. Over a two year period between 2006 and 2008, cases with altered mental state were identified on daily rounds by the palliative care medical team and consecutively referred for delirium diagnosis according to DSM-IV criteria [13] by the research team
General
Table 1 describes baseline demographics; mean age was 70 years and sex was fairly evenly divided. Comorbid dementia was present in 27 cases: 10 vascular, 7 Alzheimer's, 5 alcohol-related, 4 unspecified, and 1 malignant CNS neoplasm.
Patients were assessed on a total of 303 study visits with a range of 2–9 assessments per case across the population. The number of patients assessed at each visit was 100 for visits one and two, 56 for visit three, 26 for visit 4, 15 for visit 5, 11 for visit 6, 8
Discussion
Longitudinal studies are crucial to gaining a more complete understanding of delirium phenomenology during the course of an episode to enable a more comprehensive appreciation of core phenotypic domains that typify the syndrome. These will inform the underlying endophenotype relating to the neuropathogenesis of delirium. There is very limited study of the longitudinal course of motor profile in delirium and no studies on the stability of motor subtypes over time. While some work [17], [18] has
Conclusions
This work contributes to the body of information supporting the utility of the DMSS by demonstrating its use over serial assessment as well as its capacity to distinguish patient subgroups that share core cognitive features of delirium but have differing noncognitive phenomenological profiles. A principal finding is that full syndromal delirium is almost invariably characterised by alterations to motor activity that meet criteria for either hypoactive and/or hyperactive motor subtype as per the
Sources of funding
This study was supported through departmental funds at Limerick Mental Health services.
Conflict of interest
Unrelated to this research, Dr. Meagher has received research grant funding from Astra-Zeneca and has acted as a advisory consultant for Pfizer, Eli-Lilly, Bristol-Meyers, and Janssen Pharmaceuticals as well as receiving travel support from Smith-Kline Beecham, Eli-Lilly, Astra-Zeneca, Novartis, Wyeth, and Bristol-Meyers Pharmaceuticals Ltd. Dr. Trzepacz is a full-time salaried employee of Eli Lilly and Company.
Acknowledgement
The authors wish to acknowledge the support and co-operation of nursing and medical staff at Milford Hospice Palliative care centre.
References (29)
- et al.
Motor symptoms in 100 patients with delirium versus control subjects: comparison of subtyping methods
Psychosomatics
(2008) - et al.
An open trial of olanzapine for the treatment of delirium in hospitalised cancer patients
Psychosomatics
(2002) - et al.
Validating a new clinical subtyping scheme for delirium with electronic motion analysis
Psychiatry Res
(2010) - et al.
Delirium phenomenology: what can we learn from the symptoms of delirium?
J Psychosom Res
(2008) - et al.
A longitudinal study of motor subtypes in delirium: relationship with other phenomenology, etiology, medication exposure and prognosis
J Psychosom Res
(2011) - et al.
Validation of a cognitive test for delirium in medical ICU patients
Psychosomatics
(1996) - et al.
Defining delirium for the international classification of diseases
J Psychosom Res
(2008) Motor subtypes of delirium: past, present, and future
Int Rev Psychiatry
(2009)- et al.
Efficacy of neuroleptics for hypoactive delirium
J Neuropsychiatry Clin Neurosci
(1994) - et al.
Efficacy of risperidone in treating the hyperactive symptoms of delirium
Int Clin Psychopharmacol
(2004)
Aripiprazole and haloperidol in the treatment of delirium
Aust N Z J Psychiatry
A new data-based motor subtype schema for delirium
J Neuropsychiatry Clin Neurosci
Phenomenological and neuropsychological profile across motor variants in delirium in a palliative care unit
J Neuropsychiatry Clin Neurosci
Delirium and long-term cognitive impairment
Int Rev Psychiatry
Cited by (87)
Delirium and Delirium Prevention in the Emergency Department
2023, Clinics in Geriatric MedicineDelirium in a surgical context from a nursing perspective: A hybrid concept analysis
2022, International Journal of Nursing Studies AdvancesThe neuropsychological profile of delirium vulnerability: A systematic review and meta-analysis
2022, Neuroscience and Biobehavioral ReviewsUnderstanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia
2020, Journal of the American Medical Directors AssociationDiagnosing delirium in patients with dementia, a great challenge
2019, Medicina ClinicaDelirium motor subtypes and prognosis in hospitalized geriatric patients – A prospective observational study
2019, Journal of Psychosomatic Research